BrainStorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair

NEW YORK, June 20, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment... | June 20, 2023

Related Keywords

California ,United States ,Hamburg ,Germany ,Switzerland ,Israel ,Nir Naor ,Malcolm Taub ,Azurity Pharma Novaquest ,Chaim Lebovits ,John Mullaly ,Lisa Guiterman ,Arbor Pharmaceuticals ,Prnewswire Brainstorm Cell Therapeutics Inc ,California Institute For Regenerative Medicine ,National Ms Society ,Business School ,Hamburg University ,Astrazeneca ,Nasdaq ,Audit Committee ,Lifesci Advisors ,Master Of Business Administration ,European Medicines Agency ,Drug Administration ,Compensation Committee ,Brainstorm Cell Therapeutics Inc ,Tel Aviv University ,Storm Cell Therapeutics ,Board Member ,Chief Executive Officer ,Azurity Pharma ,Portfolio Management ,Investor Relations ,Commercial Ops ,Investment Banker ,Certified Public Accountant ,Chartered Financial Analyst ,Business Administration ,Orphan Drug ,California Institute ,Regenerative Medicine ,Brainstorm Cell Therapeutics ,Sci Advisors ,Brainstorm Cell Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Few ,Pune ,023 ,Rainstorm ,Fell ,Herapeutics ,Reading ,Developer ,F ,Adult ,Item ,Or ,Neurodegenerative ,Oday ,Nnounced ,He Bcli Us10501e2019 ,